Medication compliance among mentally Ill patients in public clinics in Kingston and St. Andrew, Jamaica

Andrea E. Pusey-Murray, Paul A. Bourne, Stan Warren, Janet LaGrenade, Christopher A. D. Charles
DOI: 10.4236/jbise.2010.36082                

Abstract

The Bellevue and the Hagley Park mental health outpatient clinics in Jamaica serve the majority of psychiatric patients in the country, but there is a dearth of research on medication compliance, which is a very important mental health issue. Medication compliance affects intervention outcomes. Therefore, this study seeks to examine medication compliance among psychiatric patients in Jamaica. A 33-item questionnaire which included items on demographics, health conditions, medication compliance and insightfulness was administered to a sample of 370 participants with a response rate of 93%. The majority of the participants have schizophrenia, followed by depression, bipolar disorder and drug-induced psychosis. The majority of the participants (65.3%) did not comply with their prescribed medication regimen. Medication compliance was significantly related to: gender (P < 0.05) where males were more likely to take the prescribed medication, family support (P < 0.05) where the participants who received family support (the majority being males) were more likely to take the prescribed medication, and insightfulness (P < 0.05) where the majority of participants with insightfulness were females. Locus on control was not statistically tested but a majority of the non- compliant participants reported that factors external to themselves had greater control over their disorder. Conclusion: There are three significant factors that explain the medication compliance of psychiatric patients in Jamaica. An important non-tested factor is locus of control so there needs to be more research to understand the range of factors that can inform and improve patient education about medication compliance.

Keywords

Medication Compliance; Mentally Ill; Public Clinics; Kingston; St. Andrew

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Royes, K. (1962) The incidence and features of psychosis in a Caribbean community. Journal of Social Psychiatry, 2, 1121-1125.
[2]	Burke, A.W. (1974) First admissions and planning in Jamaica. Journal of Social Psychiatry, 9, 39-45.
[3]	Hickling, F.W. (1991) Psychiatric hospital admission rates in Jamaica, 1971 and 1988. British Journal of Psychiatry, 159, 817-821.
[4]	Kane, J.M. and Marder, S.R. (1993) Psychopharmacologic treatment of schizophrenia. Schizophr Bull, 19, 287-302.
[5]	Crane, G.E. (1973) Clinical psychopharmacology in its 20th year: Late, unanticipated effects of neuroleptics may limit their use in psychiatry. Science, 181, 124-128.
[6]	Davis, J.M. and Gierl, B. (1984) Pharmacological treatment in the care of schizophrenic patients. In: Bellack, A.S., Ed. Treatment and care for schizophrenia. Grune & Stratton, Orlando.
[7]	Johnson, D.A. (1988) Drug treatment of schizophrenia. In: Bebbington, P. and McGuffin, P., Eds. Schizophrenia: The major issues. Heinemann Professional, Oxford, 158- 171.
[8]	Ellenbroek, B.A. (1993) Treatment of schizophrenia: A clinical and preclinical evaluation of neuroleptic drugs. Pharmacology & Therapeutics, 57, 1-78.
[9]	Kane, J., Honigfeld, G., Singer, J., et al. (1988) Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Archives of General Psychiatry, 45, 789-796.
[10]	Tuunainen, A., Wahlbeck, K. and Gilbody, S.M. (2002) Newer atypical antipsychotic medication in comparison to clozapine: A systematic review of randomised trials. Schizophrenia Research, 56, 1-10.
[11]	McKenzie, K. Jamaica: Community mental health services. http://www.publications.paho.org/english/Jamaica_CD_183. pdf
[12]	Bruer, J.T. (1982) Methodological rigor and citation frequency in patient compliance literature. American Journal of Public Health, 72, 911-1123.
[13]	Razali, M.S. and Yahya, H. (1995) Compliance with treatment in Schizophrenia: A drug intervention program in a developing country. Acta Psychiatrica Scandinavica, 91, 331-335.
[14]	Montgomery, L.A. (2002) The relationship between health belief model constructs and medication compliance in the treatment of bipolar disorder. Dissertation Abstracts International: Section B: The Sciences and Engineering, 62(12-B), 5974.
[15]	Cohen, N.L., Parikh, S.V. and Kennedy, S.H. (2000) Medication compliance in mood disorders: Relevance of the Health Belief Model and other determinants. Primary Care Psychiatry, 6(3), 101-110.
[16]	Lund, V.E. (2000) Perceived quality of life for persons with bipolar disorder: The role of medication compliance, family and health stress, level of coping, and health locus of control. Dissertation Abstracts International: Section B: The Sciences and Engineering, 60(7-B), 3198.
[17]	Buckalew, L.W. and Sallis, R.E. (1986) Patient compliance and medication perception. Journal of Clinical Psychology, 42(1), 49-53.
[18]	Thompson, C., Peveler, R.C., Stephenson, D. and McKendrick, J. (2000) Compliance with antidepressant medication in the treatment of major depressive disorders in primary care: A randomized comparison of fluoextine and a tricyclic antidepressant. The American Journal of Psychiatry, 157(3), 338-343.
[19]	Diaz, E., Levine, H.B., Sullivan, M.C., et al. (2001) Use of the Medication Events Monitoring System to estimate medication compliance in patients with schizophrenia. Journal of Psychiatry and Neuroscience, 26(4), 325-329.
[20]	Janssen, B., Gaebel, W., Haerter, M., Komaharadi, F., Lindel, B. and Weinmann, S. (2006) Evaluation of factors influencing medication compliance in patient treatment of psychotic disorders. Psychopharmacology, 187 (2), 229-236.
[21]	Hayward, P., Chan, N., Kemp, R. and Youle, S. (1995) Medication self-management: A preliminary report on an intervention to improve medication compliance. Journal of Mental Health, 4(5), 511-517.
[22]	Seltzer, A., Roncari, I. and Garfinkel, P.E. (1980) The effect of patient education on medication compliance. Canadian Journal of Psychiatry, 25(8), 638-645.
[23]	Cramer, J.A. and Rosenheck, R. (1999) Enhancing medication compliance for people with serious mental illness. Journal of Nervous and Mental Disease, 187(1), 53-55.
[24]	(1993) Demographic Statistics, Jamaica 1992. Statistical Institute of Jamaica, Kingston.
[25]	Garcia, J.I., Chang, C.L., Young, J.S., Lopez, S.R. and Jenkins, J.H. (2006) Family support predicts psychiatric medication use among Mexican American individuals with schizophrenia. Social Psychiatry and Psychiatric Epidemiology, 41(8), 624-631.
[26]	Hickling, F.W. (1975) An analysis of the 1873 Mental Hospital Law in Jamaica and its effect on mental treatment facilities. Jamaica Law Journal, 64-69.
[27]	Hickling, F.W. (1994) Community psychiatry and deinstitutionalization in Jamaica. Hospital & Community Psychiatry, 45, 1122-1126.
[28]	Feuertein, M., Labbe, E.E. and Kuegmierezyk, A.R. (1986) Health psychology: A psychobiological perspective. Pleneum Press, New York.
[29]	Adewuya, A.O., Ola, B.A., Mosaku, S.K., Fatoye, F.O. and Eegunranti A.B. (2006) Attitude towards antipsy- chotics among outpatients with schizophrenia in Nigeria. Acta Psychiatrica Scandinavica, 113, 207-211.
[30]	Demyttenwere, K. (1997). Compliance during treatment with antidepressants. Journal of Affective Disorder, 43, 27-39.
[31]	Mann, J.J. (1986) How medication compliance affects outcome. Psychiatric Annals, 16(10), 567-570.
[32]	Seltzer, A., Roncari, I. and Garfinkel, P.E. (1980) The effect of patient education on medication compliance. Canadian Journal of Psychiatry, 25(8), 638-645.
[33]	Cramer, J.A. and Rosenheck, R. (1999) Enhancing medication compliance for people with serious mental illness. Journal of Nervous and Mental Disease, 187(1), 53-55.
[34]	Safran, D.G., Neuman, P., Schoen, C., et al. (2002) Prescription drug coverage and seniors: how well are states closing the gap? Health Affairs, W253-W268.
[35]	Tamblyn, R., Laprise, R., Hanley, J.A., et al. (2001) Adverse events associated with prescription drug cost- sharing among poor and elderly persons. Journal of the American Medical Association, 285, 421-429.
[36]	Kane, J.M. (1985) Compliance issues in outpatient treatment. Journal of Clinical Psychopharmacology, 5, 22-27.
[37]	Hummer, M. and Fleischhacker, W.W. (1999) Ways of improving compliance. In: Lader, M. and Naber, D., Eds., Difficult clinical problems in psychiatry. Martin Dunitz, London, 229-238.
[38]	Cramer, J.A. and Rosenheck, R. (1998) Compliance with medication regimens for mental and physical disorders. Psychiatric Services, 49, 196-201.
[39]	Chen, A.M. (1991) Non-compliance in community psychiatry: A review of clinical interventions. Hospital and Community Psychiatry, 42(3), 282-287.
[40]	Voils, C.I., Steffens, D.C., Flint, E.P. and Bosworth, H.B. (2005) Social support and locus of control as predictors of adherence to antidepressant medication in an elderly population. The American Journal of Geriatric Psychiatry, 13(2), 157-165.
[41]	Meehan, A.J. (1995) From conversion to coercion: The police role in medication compliance. Psychiatric Quarterly, 66(2), 163-184.
[42]	Perkins, D.M. (2002) Predictors of non-compliance in patients with schizophrenia. Journal of Clinical Psychiatry, 63(12), 1121-1181.
[43]	(2008) Mental health and substance abuse unit. Annual Report, Ministry of Health, Jamaica (MOH), Kingston.